SOUTH SAN FRANCISCO, CA--(Marketwired - Mar 7, 2016) - Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) announced today that the U.S. Food and Drug Administration has provided written feedback on the ...

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a fatal motor neuron disease that causes people to gradually lose control of their muscles. There is no cure, and current ...

COLUMBUS, Ohio, May 5 Roxane Laboratories, Inc. announcedtoday the approval of its Abbreviated New Drug Application (ANDA) forRopinirole Hydrochloride Tablets, 0.25mg ...

SOUTH SAN FRANCISCO, Calif., Oct. 11, 2017 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases ...

Drug maker Dr Reddy's Laboratories (DRL) gained over 1% to touch an intraday high of 1,634 on Thursday after company launched Ropinirole Hydrochloride XR tablets in the US. Ropinirole Hydrochloride is ...

Glenmark Generics Inc., USA (GGI), a subsidiary of Glenmark Generics Limited (GGL), has received ANDA approval from the United States Food and Drug Administration (US FDA) for ropinirole hydrochloride ...

Philadelphia, PA (August 1, 2004) – New data published in the August issue of SLEEP shows that patients with primary Restless Legs Syndrome (RLS) and with periodic leg movements during sleep (PLMS), ...

May 12, 2005 — The U.S. Food and Drug Administration (FDA) has approved ropinirole HCl tablets for the treatment of moderate to severe primary restless legs syndrome (RLS) in adults, budesonide ...

Research Triangle Park, NC (December 15, 2004) – Study results published today in the journal Movement Disorders show that Requipâ(ropinirole HCl) Tablets effectively treats the symptoms of primary ...

Co announces that the U.S. FDA has accepted for filing the application by its partner, GlaxoSmithKline (GSK), for REQUIP XL 24-Hour Extended-Release Tablets, the proposed brand name for a once-daily ...